Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO11192 | Hedera helix | Species | Araliaceae | Eukaryota | TCM_Taiwan* | |||
NPO18851 | Psychotria klugii | Species | Rubiaceae | Eukaryota |
PMID[12880315] |
|||
NPO26637.1 | Mentha aquatica var. citrata | Varieties | Lamiaceae | Eukaryota | UNPD* | |||
NPO25409 | Ascochyta caulina | Species | Didymellaceae | Eukaryota | UNPD* | |||
NPO5056 | Helichrysum heterolasium | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO2690 | Carapichea ipecacuanha | Species | Rubiaceae | Eukaryota | UNPD* | |||
NPO2719 | Amauroascus aureus | Species | Onygenaceae | Eukaryota | UNPD* | |||
NPO24211 | Parmelia cetrarioides | Species | Parmeliaceae | Eukaryota | UNPD* | |||
NPO24848 | Acodontaster conspicuus | Species | Odontasteridae | Eukaryota | UNPD* | |||
NPO25098 | Spinacia glabra | Species | Chenopodiaceae | Eukaryota | UNPD* | |||
NPO24646 | Coryphantha elephantidens | Species | Cactaceae | Eukaryota | UNPD* | |||
NPO24728 | Tragopogon porrifolius | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO21010 | Streptomyces avidinii | Species | Streptomycetaceae | Bacteria | UNPD* | |||
NPO24880 | Bacterial str | NA | NA | NA | UNPD* | |||
NPO22548 | Osteospermum jucundum | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO25360 | Helminthosporium ravenelii | Species | Massarinaceae | Eukaryota | UNPD* | |||
NPO23138 | Swainsona salsula | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO24521 | Helichrysum revolutum | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO23623 | Hirsutella nivea | Species | Ophiocordycipitaceae | Eukaryota | UNPD* | |||
NPO2690 | Carapichea ipecacuanha | Species | Rubiaceae | Eukaryota | TM-MC* | |||
NPO26128 | Clonostachys rosea | Species | Bionectriaceae | Eukaryota | UNPD* | |||
NPO18432 | Poria corticola | Species | Coccinellidae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT2844 | Cell Line | MES-SA | Homo sapiens | Activity | = | 0.88 | 15828831 | |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 40 | nM | 17585747 |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 40 | nM | 17585747 |
NPT90 | Cell Line | DU-145 | Homo sapiens | IC50 | = | 60 | nM | 17585747 |
NPT133 | Cell Line | ZR-75-1 | Homo sapiens | IC50 | = | 100 | nM | 17585747 |
NPT2 | Others | Unspecified | IC50 | > | 2000 | nM | 17585747 | |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 56 | nM | 11170658 |
NPT992 | Organism | Entamoeba histolytica | Entamoeba histolytica | IC50 | = | 1.05 | ug/ml | 11374974 |
NPT2645 | Organism | Giardia intestinalis | Giardia intestinalis | IC50 | = | 0.41 | ug/ml | 11374974 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 33 | nM | 2778449 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IZ | = | 35 | mm | 2778449 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IZ | = | 25 | mm | 2778449 |
NPT168 | Cell Line | P388 | Mus musculus | IC50 | = | 7 | nM | 2778449 |
NPT168 | Cell Line | P388 | Mus musculus | IZ | > | 40 | mm | 2778449 |
NPT168 | Cell Line | P388 | Mus musculus | IZ | = | 40 | mm | 2778449 |
NPT168 | Cell Line | P388 | Mus musculus | IZ | = | 20 | mm | 2778449 |
NPT91 | Cell Line | KB | Homo sapiens | ED50 | < | 1 | ug/ml | 7130986 |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 0.03 | ug/ml | 12880315 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.0727 | ug/ml | 12880315 |
NPT2 | Others | Unspecified | Ratio IC50 | = | 6 | 12880315 | ||
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.078 | ug/ml | 12880315 |
NPT2 | Others | Unspecified | Ratio IC50 | = | 5 | 12880315 | ||
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC90 | = | 0.13 | ug/ml | 12880315 |
NPT189 | Cell Line | Vero | Chlorocebus aethiops | IC50 | = | 0.42 | ug/ml | 12880315 |
NPT2536 | Individual Protein | Leukocyte adhesion glycoprotein LFA-1 alpha | Homo sapiens | MIC | = | 0.26 | ug/ml | 12880315 |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 0.38 | ug/ml | 12880315 |
NPT2 | Others | Unspecified | Ratio | = | 1.53 | 12880315 | ||
NPT2536 | Individual Protein | Leukocyte adhesion glycoprotein LFA-1 alpha | Homo sapiens | IC50 | > | 50 | ug/ml | 12880315 |
NPT992 | Organism | Entamoeba histolytica | Entamoeba histolytica | MIC | = | 2900 | nM | 10479310 |
NPT2 | Others | Unspecified | IC50 | = | 110 | nM | 15974627 | |
NPT2 | Others | Unspecified | MIC | = | 300 | nM | 15974627 | |
NPT2 | Others | Unspecified | Inhibition | = | 18 | % | 15974627 | |
NPT2 | Others | Unspecified | Inhibition | = | 50 | % | 15974627 | |
NPT2 | Others | Unspecified | Inhibition | = | 69 | % | 15974627 | |
NPT2 | Others | Unspecified | IC50 | = | 83 | nM | 15974627 | |
NPT396 | Cell Line | T47D | Homo sapiens | Activity | = | 58.8 | ug/ml | 15974627 |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 108 | nM | 19463002 |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 120 | nM | 19572738 |
NPT65 | Cell Line | HepG2 | Homo sapiens | Inhibition | = | 43 | % | 20485427 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Inhibition | = | 0 | % | 20485427 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Inhibition | = | 99 | % | 20485427 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Inhibition | = | 100 | % | 20485427 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | EC50 | = | 10.15 | nM | 18579783 |
NPT1229 | Cell Line | Huh-7 | Homo sapiens | CC50 | = | 116.3 | nM | 18579783 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | EC50 | = | 22.94 | nM | 18579783 |
NPT5051 | Individual Protein | Putative hydrolase RBBP9 | Homo sapiens | IC50 | = | 7800 | nM | 20207142 |
NPT5051 | Individual Protein | Putative hydrolase RBBP9 | Homo sapiens | Inhibition | = | 62 | % | 20207142 |
NPT5051 | Individual Protein | Putative hydrolase RBBP9 | Homo sapiens | Inhibition | = | 51 | % | 20207142 |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 0.19 | nM | 20971006 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Ratio IC50 | = | 0.4 | 20971006 | |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | Potency | = | 920 | nM | PubChem BioAssay data set |
NPT537 | Individual Protein | Ras-related protein Rab-9A | Homo sapiens | Potency | = | 18356.4 | nM | PubChem BioAssay data set |
NPT940 | Individual Protein | Serine/threonine-protein kinase mTOR | Homo sapiens | Potency | = | 5211.9 | nM | PubChem BioAssay data set |
NPT538 | Individual Protein | Niemann-Pick C1 protein | Homo sapiens | Potency | = | 58047.9 | nM | PubChem BioAssay data set |
NPT940 | Individual Protein | Serine/threonine-protein kinase mTOR | Homo sapiens | Potency | = | 1849.3 | nM | PubChem BioAssay data set |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 127 | nM | 21183259 |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 190 | nM | 21316959 |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 1299 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 1299.5 | nM | PubChem BioAssay data set | |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 670.2 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 259.2 | nM | PubChem BioAssay data set | |
NPT475 | Organism | Plasmodium yoelii | Plasmodium yoelii | IC50 | = | 7.49 | nM | 22096101 |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 80 | nM | 21875063 |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 281.8 | nM | PubChem BioAssay data set | |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 3548.1 | nM | PubChem BioAssay data set | |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 29934.9 | nM | PubChem BioAssay data set | |
NPT71 | Cell Line | HEK293 | Homo sapiens | Potency | 183.5 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 326.3 | nM | PubChem BioAssay data set | ||
NPT519 | Cell Line | SH-SY5Y | Homo sapiens | Potency | 251.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 223.9 | nM | PubChem BioAssay data set | ||
NPT219 | Individual Protein | Alpha-1a adrenergic receptor | Rattus norvegicus | IC50 | = | 6527 | nM | DrugMatrix in vitro pharmacology data |
NPT219 | Individual Protein | Alpha-1a adrenergic receptor | Rattus norvegicus | Ki | = | 2642 | nM | DrugMatrix in vitro pharmacology data |
NPT220 | Individual Protein | Alpha-1b adrenergic receptor | Rattus norvegicus | IC50 | = | 1934 | nM | DrugMatrix in vitro pharmacology data |
NPT220 | Individual Protein | Alpha-1b adrenergic receptor | Rattus norvegicus | Ki | = | 1071 | nM | DrugMatrix in vitro pharmacology data |
NPT222 | Individual Protein | Alpha-2a adrenergic receptor | Homo sapiens | IC50 | = | 38 | nM | DrugMatrix in vitro pharmacology data |
NPT222 | Individual Protein | Alpha-2a adrenergic receptor | Homo sapiens | Ki | = | 14 | nM | DrugMatrix in vitro pharmacology data |
NPT224 | Individual Protein | Alpha-2c adrenergic receptor | Homo sapiens | IC50 | = | 182 | nM | DrugMatrix in vitro pharmacology data |
NPT224 | Individual Protein | Alpha-2c adrenergic receptor | Homo sapiens | Ki | = | 26 | nM | DrugMatrix in vitro pharmacology data |
NPT2 | Others | Unspecified | IC50 | = | 2356 | nM | DrugMatrix in vitro pharmacology data | |
NPT2 | Others | Unspecified | Ki | = | 2094 | nM | DrugMatrix in vitro pharmacology data | |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 140 | nM | 22196513 |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 19.77 | nM | 22750008 |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 300 | nM | 22889556 |
NPT705 | Individual Protein | Solute carrier family 22 member 5 | Homo sapiens | Activity | = | 16.6 | % | 10525100 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 115600 | nM | 11716514 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 130300 | nM | 11716514 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 2400 | nM | 11716514 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 207100 | nM | 11716514 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 35100 | nM | 11716514 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 9200 | nM | 11716514 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 9600 | nM | 11716514 |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 251.2 | nM | PubChem BioAssay data set | |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 124830 | nM | 23168082 |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 170 | nM | 23195733 |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 330 | nM | 23347684 |
NPT2 | Others | Unspecified | Potency | 149.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 188.4 | nM | PubChem BioAssay data set | ||
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 129 | nM | 23896611 |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 41 | nM | 24077524 |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 129 | nM | 24900630 |
NPT2645 | Organism | Giardia intestinalis | Giardia intestinalis | IC50 | = | 830 | nM | 24502360 |
NPT3535 | Organism | Entamoeba histolytica HM-1:IMSS | Entamoeba histolytica HM-1:IMSS | IC50 | = | 2180 | nM | 24502360 |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 92 | nM | 24468411 |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 100 | nM | 24602791 |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 50 | nM | 10.1039/C3MD00310H |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 268.3 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 105.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 668.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 133.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 595.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 211.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10682.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2129.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2660.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 100 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 84.1 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 10590.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 3757.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 84.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 37.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3757.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 220.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9520.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 26601.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 167.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 4252.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 23.7 | nM | PubChem BioAssay data set | ||
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 44668.4 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 1508.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10590.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9200 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 11883.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 398.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 118.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 237.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 18.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1059.1 | nM | PubChem BioAssay data set | ||
NPT106 | Individual Protein | Peroxisome proliferator-activated receptor delta | Homo sapiens | Potency | 33488.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 334.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1412.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 631 | nM | PubChem BioAssay data set | ||
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 400 | nM | 10.1039/C3MD20377H |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 61 | nM | 25451997 |
NPT2 | Others | Unspecified | IC50 | = | 50 | nM | 25461309 | |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 125 | nM | 25544689 |
NPT943 | Individual Protein | Hexose transporter 1 | Plasmodium falciparum | IC50 | = | 90 | nM | 10.6019/CHEMBL3433997 |
NPT944 | Individual Protein | Glucose transporter | Leishmania mexicana | Inhibition | = | 90.27 | % | 10.6019/CHEMBL3433997 |
NPT944 | Individual Protein | Glucose transporter | Leishmania mexicana | IC50 | = | 81 | nM | 10.6019/CHEMBL3433997 |
NPT942 | Individual Protein | Glucose transporter | Homo sapiens | IC50 | = | 108 | nM | 10.6019/CHEMBL3433997 |
NPT942 | Individual Protein | Glucose transporter | Homo sapiens | Inhibition | = | 96.79 | % | 10.6019/CHEMBL3433997 |
NPT943 | Individual Protein | Hexose transporter 1 | Plasmodium falciparum | Inhibition | = | 94.03 | % | 10.6019/CHEMBL3433997 |
NPT2 | Others | Unspecified | Ratio | = | 53 | 21051535 | ||
NPT2 | Others | Unspecified | Ratio | = | 0.6 | 21051535 | ||
NPT2 | Others | Unspecified | Ratio | = | 2.6 | 21051535 | ||
NPT2 | Others | Unspecified | Ratio | = | 78 | 21051535 | ||
NPT2 | Others | Unspecified | Ratio | = | 66 | 21051535 | ||
NPT2 | Others | Unspecified | Potency | 266 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 25118.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | 10000 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3010.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | 16.34 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | 11.58 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | 1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | 32.66 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | 61.47 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 749.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | 2.28 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1693 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 943.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | 8.31 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | 22.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | 947.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 17782.8 | nM | PubChem BioAssay data set | ||
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 30 | nM | 26235033 |
NPT858 | Cell Line | LNCaP | Homo sapiens | IC50 | = | 37 | nM | 26187015 |
NPT306 | Cell Line | PC-3 | Homo sapiens | IC50 | = | 35 | nM | 26187015 |
NPT90 | Cell Line | DU-145 | Homo sapiens | IC50 | = | 33 | nM | 26187015 |
NPT858 | Cell Line | LNCaP | Homo sapiens | IC50 | = | 27 | nM | 26187015 |
NPT306 | Cell Line | PC-3 | Homo sapiens | IC50 | = | 27 | nM | 26187015 |
NPT90 | Cell Line | DU-145 | Homo sapiens | IC50 | = | 25 | nM | 26187015 |
NPT306 | Cell Line | PC-3 | Homo sapiens | IC50 | = | 29 | nM | 26187015 |
NPT90 | Cell Line | DU-145 | Homo sapiens | IC50 | = | 24 | nM | 26187015 |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 104 | nM | 26264839 |
NPT3535 | Organism | Entamoeba histolytica HM-1:IMSS | Entamoeba histolytica HM-1:IMSS | IC50 | = | 2180 | nM | 26517282 |
NPT2645 | Organism | Giardia intestinalis | Giardia intestinalis | IC50 | = | 830 | nM | 26517282 |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 61 | nM | 26832222 |
NPT1161 | Cell Line | CHO | Cricetulus griseus | IC50 | = | 400 | nM | 10.1039/C5MD00343A |
NPT165 | Cell Line | HeLa | Homo sapiens | IC50 | = | 370 | nM | 26974377 |
NPT2 | Others | Unspecified | IC50 | = | 50 | nM | 27210430 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC187022 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC80129 |
0.9539 | High Similarity | NPC121275 |
0.9539 | High Similarity | NPC284183 |
0.9539 | High Similarity | NPC4138 |
0.9295 | High Similarity | NPC109925 |
0.9241 | High Similarity | NPC128019 |
0.9241 | High Similarity | NPC136860 |
0.9241 | High Similarity | NPC476567 |
0.9221 | High Similarity | NPC475393 |
0.906 | High Similarity | NPC7467 |
0.8993 | High Similarity | NPC210437 |
0.8993 | High Similarity | NPC106295 |
0.8993 | High Similarity | NPC476144 |
0.8993 | High Similarity | NPC16107 |
0.8993 | High Similarity | NPC51957 |
0.8973 | High Similarity | NPC474915 |
0.8973 | High Similarity | NPC328750 |
0.8973 | High Similarity | NPC188163 |
0.8973 | High Similarity | NPC213206 |
0.8904 | High Similarity | NPC314682 |
0.8903 | High Similarity | NPC216816 |
0.8897 | High Similarity | NPC253429 |
0.8896 | High Similarity | NPC247639 |
0.8896 | High Similarity | NPC25084 |
0.8874 | High Similarity | NPC60538 |
0.8874 | High Similarity | NPC207824 |
0.8816 | High Similarity | NPC97221 |
0.8816 | High Similarity | NPC220858 |
0.8816 | High Similarity | NPC151895 |
0.8816 | High Similarity | NPC88249 |
0.8816 | High Similarity | NPC192768 |
0.8758 | High Similarity | NPC108434 |
0.8758 | High Similarity | NPC475215 |
0.8758 | High Similarity | NPC277669 |
0.8758 | High Similarity | NPC76213 |
0.8701 | High Similarity | NPC210148 |
0.8701 | High Similarity | NPC233029 |
0.8667 | High Similarity | NPC239584 |
0.8654 | High Similarity | NPC126519 |
0.8654 | High Similarity | NPC203784 |
0.8654 | High Similarity | NPC170503 |
0.8654 | High Similarity | NPC146288 |
0.8627 | High Similarity | NPC92541 |
0.8621 | High Similarity | NPC160692 |
0.8609 | High Similarity | NPC185838 |
0.8606 | High Similarity | NPC475479 |
0.8606 | High Similarity | NPC243454 |
0.859 | High Similarity | NPC5238 |
0.859 | High Similarity | NPC110416 |
0.859 | High Similarity | NPC207757 |
0.859 | High Similarity | NPC172765 |
0.859 | High Similarity | NPC469817 |
0.859 | High Similarity | NPC39701 |
0.859 | High Similarity | NPC138487 |
0.859 | High Similarity | NPC216459 |
0.859 | High Similarity | NPC184026 |
0.859 | High Similarity | NPC54379 |
0.859 | High Similarity | NPC276588 |
0.859 | High Similarity | NPC189266 |
0.859 | High Similarity | NPC2413 |
0.859 | High Similarity | NPC193949 |
0.859 | High Similarity | NPC249797 |
0.859 | High Similarity | NPC41178 |
0.859 | High Similarity | NPC204828 |
0.859 | High Similarity | NPC295691 |
0.859 | High Similarity | NPC278799 |
0.859 | High Similarity | NPC127674 |
0.8562 | High Similarity | NPC24233 |
0.8562 | High Similarity | NPC135538 |
0.8562 | High Similarity | NPC428 |
0.8562 | High Similarity | NPC147390 |
0.8562 | High Similarity | NPC476571 |
0.8562 | High Similarity | NPC475959 |
0.8562 | High Similarity | NPC246587 |
0.8526 | High Similarity | NPC477564 |
0.8526 | High Similarity | NPC2295 |
0.8519 | High Similarity | NPC66573 |
0.8516 | High Similarity | NPC476568 |
0.8509 | High Similarity | NPC317272 |
0.8509 | High Similarity | NPC256012 |
0.8509 | High Similarity | NPC250846 |
0.8509 | High Similarity | NPC268503 |
0.8509 | High Similarity | NPC240841 |
0.8509 | High Similarity | NPC42549 |
0.8497 | Intermediate Similarity | NPC144863 |
0.8497 | Intermediate Similarity | NPC179825 |
0.8497 | Intermediate Similarity | NPC191376 |
0.8497 | Intermediate Similarity | NPC321505 |
0.8428 | Intermediate Similarity | NPC111485 |
0.8421 | Intermediate Similarity | NPC294249 |
0.8418 | Intermediate Similarity | NPC234392 |
0.8418 | Intermediate Similarity | NPC31311 |
0.8414 | Intermediate Similarity | NPC160193 |
0.8397 | Intermediate Similarity | NPC326316 |
0.8397 | Intermediate Similarity | NPC81733 |
0.8397 | Intermediate Similarity | NPC476579 |
0.8377 | Intermediate Similarity | NPC476151 |
0.8364 | Intermediate Similarity | NPC129518 |
0.8364 | Intermediate Similarity | NPC251580 |
0.8364 | Intermediate Similarity | NPC41376 |
0.8364 | Intermediate Similarity | NPC12424 |
0.8354 | Intermediate Similarity | NPC99659 |
0.8354 | Intermediate Similarity | NPC325871 |
0.8344 | Intermediate Similarity | NPC204947 |
0.8323 | Intermediate Similarity | NPC130941 |
0.8314 | Intermediate Similarity | NPC191132 |
0.8314 | Intermediate Similarity | NPC60295 |
0.8313 | Intermediate Similarity | NPC477080 |
0.8303 | Intermediate Similarity | NPC317439 |
0.8303 | Intermediate Similarity | NPC317145 |
0.8303 | Intermediate Similarity | NPC227060 |
0.8303 | Intermediate Similarity | NPC63646 |
0.8303 | Intermediate Similarity | NPC115284 |
0.8303 | Intermediate Similarity | NPC198498 |
0.8303 | Intermediate Similarity | NPC10908 |
0.8303 | Intermediate Similarity | NPC276890 |
0.8303 | Intermediate Similarity | NPC76682 |
0.8282 | Intermediate Similarity | NPC304659 |
0.8282 | Intermediate Similarity | NPC86144 |
0.8282 | Intermediate Similarity | NPC476573 |
0.8282 | Intermediate Similarity | NPC81247 |
0.8282 | Intermediate Similarity | NPC35627 |
0.8269 | Intermediate Similarity | NPC103379 |
0.8269 | Intermediate Similarity | NPC477565 |
0.8269 | Intermediate Similarity | NPC219162 |
0.8256 | Intermediate Similarity | NPC175890 |
0.8256 | Intermediate Similarity | NPC82457 |
0.8256 | Intermediate Similarity | NPC11296 |
0.8256 | Intermediate Similarity | NPC48490 |
0.8256 | Intermediate Similarity | NPC274661 |
0.8256 | Intermediate Similarity | NPC281581 |
0.825 | Intermediate Similarity | NPC476572 |
0.8247 | Intermediate Similarity | NPC130926 |
0.8242 | Intermediate Similarity | NPC69712 |
0.8242 | Intermediate Similarity | NPC26240 |
0.8242 | Intermediate Similarity | NPC477562 |
0.8242 | Intermediate Similarity | NPC6152 |
0.8228 | Intermediate Similarity | NPC37272 |
0.8224 | Intermediate Similarity | NPC323204 |
0.8221 | Intermediate Similarity | NPC24465 |
0.8221 | Intermediate Similarity | NPC232514 |
0.8221 | Intermediate Similarity | NPC276944 |
0.8221 | Intermediate Similarity | NPC238530 |
0.8218 | Intermediate Similarity | NPC256124 |
0.8171 | Intermediate Similarity | NPC13916 |
0.8171 | Intermediate Similarity | NPC264850 |
0.816 | Intermediate Similarity | NPC189470 |
0.8155 | Intermediate Similarity | NPC293093 |
0.8151 | Intermediate Similarity | NPC172403 |
0.8144 | Intermediate Similarity | NPC477020 |
0.8144 | Intermediate Similarity | NPC66341 |
0.8144 | Intermediate Similarity | NPC192135 |
0.8141 | Intermediate Similarity | NPC95075 |
0.8141 | Intermediate Similarity | NPC90844 |
0.8141 | Intermediate Similarity | NPC253883 |
0.8049 | Intermediate Similarity | NPC324144 |
0.8039 | Intermediate Similarity | NPC323123 |
0.8037 | Intermediate Similarity | NPC266753 |
0.8037 | Intermediate Similarity | NPC27410 |
0.8037 | Intermediate Similarity | NPC160298 |
0.8037 | Intermediate Similarity | NPC166014 |
0.8037 | Intermediate Similarity | NPC232924 |
0.8037 | Intermediate Similarity | NPC477559 |
0.8037 | Intermediate Similarity | NPC306902 |
0.8023 | Intermediate Similarity | NPC274716 |
0.8023 | Intermediate Similarity | NPC167116 |
0.8023 | Intermediate Similarity | NPC254441 |
0.8013 | Intermediate Similarity | NPC11147 |
0.8012 | Intermediate Similarity | NPC286119 |
0.8012 | Intermediate Similarity | NPC93593 |
0.8012 | Intermediate Similarity | NPC244112 |
0.8 | Intermediate Similarity | NPC136508 |
0.8 | Intermediate Similarity | NPC167546 |
0.8 | Intermediate Similarity | NPC477563 |
0.8 | Intermediate Similarity | NPC212794 |
0.8 | Intermediate Similarity | NPC39103 |
0.8 | Intermediate Similarity | NPC13504 |
0.8 | Intermediate Similarity | NPC169743 |
0.8 | Intermediate Similarity | NPC16805 |
0.8 | Intermediate Similarity | NPC96603 |
0.8 | Intermediate Similarity | NPC2770 |
0.8 | Intermediate Similarity | NPC306843 |
0.8 | Intermediate Similarity | NPC196447 |
0.8 | Intermediate Similarity | NPC253043 |
0.8 | Intermediate Similarity | NPC78222 |
0.8 | Intermediate Similarity | NPC302527 |
0.7987 | Intermediate Similarity | NPC470925 |
0.7987 | Intermediate Similarity | NPC274026 |
0.7975 | Intermediate Similarity | NPC106786 |
0.7974 | Intermediate Similarity | NPC211468 |
0.7974 | Intermediate Similarity | NPC170170 |
0.7974 | Intermediate Similarity | NPC219233 |
0.7965 | Intermediate Similarity | NPC223690 |
0.7965 | Intermediate Similarity | NPC285931 |
0.7965 | Intermediate Similarity | NPC290582 |
0.7965 | Intermediate Similarity | NPC229373 |
0.7965 | Intermediate Similarity | NPC222661 |
0.7965 | Intermediate Similarity | NPC90998 |
0.7965 | Intermediate Similarity | NPC73492 |
0.7965 | Intermediate Similarity | NPC290005 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC187022 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD7298 | Approved |
0.8993 | High Similarity | NPD4584 | Approved |
0.8973 | High Similarity | NPD4664 | Clinical (unspecified phase) |
0.8679 | High Similarity | NPD6107 | Approved |
0.8627 | High Similarity | NPD6030 | Approved |
0.8627 | High Similarity | NPD6031 | Approved |
0.8506 | High Similarity | NPD3639 | Approved |
0.8506 | High Similarity | NPD3641 | Approved |
0.8506 | High Similarity | NPD3640 | Phase 3 |
0.8408 | Intermediate Similarity | NPD4772 | Phase 2 |
0.8408 | Intermediate Similarity | NPD4773 | Phase 2 |
0.8395 | Intermediate Similarity | NPD4166 | Phase 2 |
0.8312 | Intermediate Similarity | NPD3124 | Discontinued |
0.8303 | Intermediate Similarity | NPD8251 | Approved |
0.8303 | Intermediate Similarity | NPD8252 | Approved |
0.8303 | Intermediate Similarity | NPD8099 | Discontinued |
0.828 | Intermediate Similarity | NPD4017 | Approved |
0.8253 | Intermediate Similarity | NPD8156 | Discontinued |
0.8194 | Intermediate Similarity | NPD7598 | Phase 2 |
0.8108 | Intermediate Similarity | NPD5718 | Phase 2 |
0.8105 | Intermediate Similarity | NPD7045 | Clinical (unspecified phase) |
0.807 | Intermediate Similarity | NPD6618 | Phase 2 |
0.8049 | Intermediate Similarity | NPD7201 | Clinical (unspecified phase) |
0.8047 | Intermediate Similarity | NPD6297 | Approved |
0.8026 | Intermediate Similarity | NPD6028 | Clinical (unspecified phase) |
0.8026 | Intermediate Similarity | NPD6029 | Clinical (unspecified phase) |
0.7965 | Intermediate Similarity | NPD6851 | Approved |
0.7965 | Intermediate Similarity | NPD8053 | Approved |
0.7965 | Intermediate Similarity | NPD8054 | Approved |
0.7965 | Intermediate Similarity | NPD6853 | Approved |
0.7961 | Intermediate Similarity | NPD6896 | Approved |
0.7961 | Intermediate Similarity | NPD6895 | Approved |
0.7929 | Intermediate Similarity | NPD5312 | Approved |
0.7929 | Intermediate Similarity | NPD5313 | Approved |
0.7919 | Intermediate Similarity | NPD2669 | Clinical (unspecified phase) |
0.7892 | Intermediate Similarity | NPD7802 | Discontinued |
0.7853 | Intermediate Similarity | NPD6818 | Clinical (unspecified phase) |
0.7844 | Intermediate Similarity | NPD4010 | Discontinued |
0.7799 | Intermediate Similarity | NPD1424 | Approved |
0.7785 | Intermediate Similarity | NPD2422 | Clinical (unspecified phase) |
0.7785 | Intermediate Similarity | NPD3845 | Phase 1 |
0.7758 | Intermediate Similarity | NPD6788 | Approved |
0.775 | Intermediate Similarity | NPD3647 | Clinical (unspecified phase) |
0.7746 | Intermediate Similarity | NPD8453 | Clinical (unspecified phase) |
0.7733 | Intermediate Similarity | NPD5752 | Clinical (unspecified phase) |
0.7722 | Intermediate Similarity | NPD5241 | Discontinued |
0.7716 | Intermediate Similarity | NPD7261 | Clinical (unspecified phase) |
0.7711 | Intermediate Similarity | NPD7831 | Phase 2 |
0.7711 | Intermediate Similarity | NPD7833 | Phase 2 |
0.7711 | Intermediate Similarity | NPD7832 | Clinical (unspecified phase) |
0.7706 | Intermediate Similarity | NPD5602 | Clinical (unspecified phase) |
0.7658 | Intermediate Similarity | NPD3977 | Clinical (unspecified phase) |
0.7628 | Intermediate Similarity | NPD1632 | Clinical (unspecified phase) |
0.7622 | Intermediate Similarity | NPD7109 | Clinical (unspecified phase) |
0.7622 | Intermediate Similarity | NPD7110 | Phase 1 |
0.7614 | Intermediate Similarity | NPD5087 | Clinical (unspecified phase) |
0.7595 | Intermediate Similarity | NPD3060 | Approved |
0.7595 | Intermediate Similarity | NPD4162 | Approved |
0.7582 | Intermediate Similarity | NPD554 | Clinical (unspecified phase) |
0.7576 | Intermediate Similarity | NPD5720 | Discontinued |
0.7562 | Intermediate Similarity | NPD7124 | Phase 2 |
0.7532 | Intermediate Similarity | NPD3110 | Approved |
0.7532 | Intermediate Similarity | NPD3109 | Approved |
0.75 | Intermediate Similarity | NPD5084 | Clinical (unspecified phase) |
0.7485 | Intermediate Similarity | NPD5978 | Approved |
0.7485 | Intermediate Similarity | NPD4727 | Phase 1 |
0.7485 | Intermediate Similarity | NPD5977 | Approved |
0.7485 | Intermediate Similarity | NPD6687 | Approved |
0.7485 | Intermediate Similarity | NPD6688 | Approved |
0.7469 | Intermediate Similarity | NPD1754 | Clinical (unspecified phase) |
0.7457 | Intermediate Similarity | NPD5708 | Clinical (unspecified phase) |
0.7455 | Intermediate Similarity | NPD6876 | Approved |
0.7455 | Intermediate Similarity | NPD6875 | Approved |
0.7453 | Intermediate Similarity | NPD6783 | Clinical (unspecified phase) |
0.7446 | Intermediate Similarity | NPD8095 | Phase 1 |
0.7442 | Intermediate Similarity | NPD4481 | Phase 3 |
0.7442 | Intermediate Similarity | NPD2898 | Approved |
0.744 | Intermediate Similarity | NPD4581 | Clinical (unspecified phase) |
0.7436 | Intermediate Similarity | NPD2653 | Approved |
0.7432 | Intermediate Similarity | NPD7034 | Discontinued |
0.743 | Intermediate Similarity | NPD7291 | Discontinued |
0.7427 | Intermediate Similarity | NPD3051 | Approved |
0.7427 | Intermediate Similarity | NPD6071 | Discontinued |
0.7391 | Intermediate Similarity | NPD5307 | Clinical (unspecified phase) |
0.7384 | Intermediate Similarity | NPD2969 | Approved |
0.7384 | Intermediate Similarity | NPD2970 | Approved |
0.7378 | Intermediate Similarity | NPD6662 | Clinical (unspecified phase) |
0.7371 | Intermediate Similarity | NPD7479 | Phase 2 |
0.7355 | Intermediate Similarity | NPD3532 | Approved |
0.7355 | Intermediate Similarity | NPD3530 | Approved |
0.7355 | Intermediate Similarity | NPD3531 | Approved |
0.7351 | Intermediate Similarity | NPD7258 | Clinical (unspecified phase) |
0.7346 | Intermediate Similarity | NPD2120 | Phase 2 |
0.7345 | Intermediate Similarity | NPD7132 | Clinical (unspecified phase) |
0.7341 | Intermediate Similarity | NPD27 | Approved |
0.7341 | Intermediate Similarity | NPD2489 | Approved |
0.7329 | Intermediate Similarity | NPD6658 | Clinical (unspecified phase) |
0.7325 | Intermediate Similarity | NPD2986 | Phase 2 |
0.7325 | Intermediate Similarity | NPD2989 | Phase 2 |
0.7321 | Intermediate Similarity | NPD4585 | Approved |
0.7321 | Intermediate Similarity | NPD2978 | Approved |
0.7321 | Intermediate Similarity | NPD2977 | Approved |
0.7312 | Intermediate Similarity | NPD6612 | Phase 2 |
0.7312 | Intermediate Similarity | NPD7153 | Discontinued |
0.7303 | Intermediate Similarity | NPD5917 | Clinical (unspecified phase) |
0.7301 | Intermediate Similarity | NPD2421 | Approved |
0.7301 | Intermediate Similarity | NPD2420 | Approved |
0.7283 | Intermediate Similarity | NPD7667 | Clinical (unspecified phase) |
0.7283 | Intermediate Similarity | NPD4083 | Discontinued |
0.7273 | Intermediate Similarity | NPD5976 | Discontinued |
0.7267 | Intermediate Similarity | NPD5177 | Phase 3 |
0.7255 | Intermediate Similarity | NPD7905 | Discontinued |
0.7244 | Intermediate Similarity | NPD4474 | Approved |
0.7244 | Intermediate Similarity | NPD4475 | Approved |
0.7222 | Intermediate Similarity | NPD6748 | Discontinued |
0.7212 | Intermediate Similarity | NPD7527 | Clinical (unspecified phase) |
0.7212 | Intermediate Similarity | NPD7526 | Approved |
0.7212 | Intermediate Similarity | NPD52 | Approved |
0.7207 | Intermediate Similarity | NPD7310 | Approved |
0.7207 | Intermediate Similarity | NPD7312 | Approved |
0.7207 | Intermediate Similarity | NPD7280 | Phase 3 |
0.7207 | Intermediate Similarity | NPD7311 | Approved |
0.7207 | Intermediate Similarity | NPD7281 | Phase 3 |
0.7207 | Intermediate Similarity | NPD7313 | Approved |
0.719 | Intermediate Similarity | NPD3055 | Approved |
0.719 | Intermediate Similarity | NPD3053 | Approved |
0.7179 | Intermediate Similarity | NPD2028 | Clinical (unspecified phase) |
0.7178 | Intermediate Similarity | NPD5160 | Discontinued |
0.7176 | Intermediate Similarity | NPD2560 | Approved |
0.7176 | Intermediate Similarity | NPD2563 | Approved |
0.717 | Intermediate Similarity | NPD6111 | Discontinued |
0.7169 | Intermediate Similarity | NPD2122 | Discontinued |
0.7167 | Intermediate Similarity | NPD7309 | Approved |
0.716 | Intermediate Similarity | NPD2459 | Approved |
0.716 | Intermediate Similarity | NPD2458 | Approved |
0.716 | Intermediate Similarity | NPD2460 | Phase 3 |
0.7152 | Intermediate Similarity | NPD1771 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD2874 | Phase 2 |
0.7124 | Intermediate Similarity | NPD5311 | Approved |
0.7124 | Intermediate Similarity | NPD5310 | Approved |
0.7123 | Intermediate Similarity | NPD5283 | Phase 1 |
0.7117 | Intermediate Similarity | NPD5754 | Discontinued |
0.711 | Intermediate Similarity | NPD5677 | Discontinued |
0.7093 | Intermediate Similarity | NPD4055 | Discovery |
0.7083 | Intermediate Similarity | NPD4005 | Discontinued |
0.7081 | Intermediate Similarity | NPD3156 | Discontinued |
0.7078 | Intermediate Similarity | NPD4098 | Discontinued |
0.707 | Intermediate Similarity | NPD5109 | Approved |
0.707 | Intermediate Similarity | NPD5111 | Phase 2 |
0.707 | Intermediate Similarity | NPD5110 | Phase 2 |
0.707 | Intermediate Similarity | NPD6812 | Clinical (unspecified phase) |
0.7065 | Intermediate Similarity | NPD5525 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD7945 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD1769 | Discontinued |
0.7055 | Intermediate Similarity | NPD44 | Approved |
0.7055 | Intermediate Similarity | NPD6364 | Approved |
0.7049 | Intermediate Similarity | NPD7906 | Approved |
0.7025 | Intermediate Similarity | NPD2674 | Phase 3 |
0.7024 | Intermediate Similarity | NPD2883 | Discontinued |
0.7022 | Intermediate Similarity | NPD42 | Phase 2 |
0.7022 | Intermediate Similarity | NPD6042 | Phase 2 |
0.7021 | Intermediate Similarity | NPD5071 | Phase 2 |
0.702 | Intermediate Similarity | NPD2668 | Approved |
0.702 | Intermediate Similarity | NPD2667 | Approved |
0.7019 | Intermediate Similarity | NPD2155 | Approved |
0.7019 | Intermediate Similarity | NPD2156 | Approved |
0.7019 | Intermediate Similarity | NPD6380 | Phase 1 |
0.7019 | Intermediate Similarity | NPD2154 | Approved |
0.7017 | Intermediate Similarity | NPD2971 | Approved |
0.7017 | Intermediate Similarity | NPD2968 | Approved |
0.7017 | Intermediate Similarity | NPD3534 | Clinical (unspecified phase) |
0.7011 | Intermediate Similarity | NPD6037 | Discontinued |
0.7006 | Intermediate Similarity | NPD6090 | Discontinued |
0.7006 | Intermediate Similarity | NPD5261 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD6873 | Phase 2 |
0.7 | Intermediate Similarity | NPD4579 | Clinical (unspecified phase) |
0.6994 | Remote Similarity | NPD4257 | Approved |
0.6994 | Remote Similarity | NPD1372 | Clinical (unspecified phase) |
0.6994 | Remote Similarity | NPD4256 | Phase 2 |
0.6983 | Remote Similarity | NPD3920 | Phase 2 |
0.6982 | Remote Similarity | NPD6357 | Discontinued |
0.6966 | Remote Similarity | NPD4498 | Clinical (unspecified phase) |
0.6962 | Remote Similarity | NPD3145 | Approved |
0.6962 | Remote Similarity | NPD3144 | Approved |
0.6959 | Remote Similarity | NPD593 | Approved |
0.6959 | Remote Similarity | NPD595 | Approved |
0.6959 | Remote Similarity | NPD5722 | Discontinued |
0.6957 | Remote Similarity | NPD3349 | Phase 2 |
0.6951 | Remote Similarity | NPD4236 | Phase 3 |
0.6951 | Remote Similarity | NPD4237 | Approved |
0.6948 | Remote Similarity | NPD1421 | Approved |
0.6948 | Remote Similarity | NPD1420 | Approved |
0.6947 | Remote Similarity | NPD5457 | Discontinued |
0.6946 | Remote Similarity | NPD4123 | Phase 3 |
0.6944 | Remote Similarity | NPD6996 | Clinical (unspecified phase) |
0.6941 | Remote Similarity | NPD4179 | Approved |
0.6941 | Remote Similarity | NPD4180 | Approved |
0.6941 | Remote Similarity | NPD1337 | Clinical (unspecified phase) |
0.6935 | Remote Similarity | NPD3921 | Approved |
0.6935 | Remote Similarity | NPD3924 | Approved |
PubChem CID   | 10219 |
ChEMBL   | CHEMBL50588 |
ZINC   |
Molecular Weight:   | 480.30 |
ALogP:   | -0.5069 |
MLogP:   | 3.99 |
XLogP:   | 4.161 |
# Rotatable Bonds:   | 12 |
Polar Surface Area:   | 52.19 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 1 |
# Rings:   | 5 |
# Heavy Atoms:   | 35 |